(Q39607993)

13 September 2017

title

Anti-tumor effects of dihydroartemisinin on human osteosarcoma (English)

1 reference

13 September 2017

Ye Ji

1

1 reference

13 September 2017

Yi-Cai Zhang

2

1 reference

13 September 2017

Liu-Bao Pei

3

1 reference

13 September 2017

Li-Li Shi

4

1 reference

13 September 2017

Jing-Long Yan

5

1 reference

13 September 2017

Xue-Hua Ma

6

1 reference

13 September 2017

publication date

14 January 2011

1 reference

Molecular and Cellular Biochemistry

13 September 2017

published in

1 reference

13 September 2017

volume

351

1 reference

13 September 2017

issue

1-2

1 reference

13 September 2017

page(s)

99-108

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-011-0716-6

13 September 2017

exact match

0 references

cites work

Multidisciplinary approach to diagnosis and management of osteosarcoma - a review of the St Vincent's Hospital experience.

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Skip metastases in osteosarcoma: experience of the Cooperative Osteosarcoma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Qinghaosu (artemisinin): an antimalarial drug from China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

A medicinal chemistry perspective on artemisinin and related endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Effects of artemisinin and its derivatives on growth inhibition and apoptosis of oral cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Oral artemisinin prevents and delays the development of 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Dihydroartemisinin downregulates vascular endothelial growth factor expression and induces apoptosis in chronic myeloid leukemia K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Dihydroartemisinin inhibits angiogenesis induced by multiple myeloma RPMI8226 cells under hypoxic conditions via downregulation of vascular endothelial growth factor expression and suppression of vascular endothelial growth factor secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Inactivation of p53 gene in human and murine osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Osteosarcoma cell lines display variable individual reactions on wildtype p53 and Rb tumour-suppressor transgenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Oncogenic activation of NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1alpha activation in C6 glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Dihydroartemisinin is an inhibitor of ovarian cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Mitochondria as the target of the pro-apoptotic protein Bax.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Life and death by death receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Checkpoints: controls that ensure the order of cell cycle events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Regulating mammalian checkpoints through Cdc25 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Regulation of the G2/M transition by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Apoptosis - the p53 network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Evidence for the Involvement of Carbon-centered Radicals in the Induction of Apoptotic Cell Death by Artemisinin Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-011-0716-6

Artemisinin induces apoptosis in human cancer cells.

21 January 2018

1 reference

12 December 2020

Artesunate and a major metabolite, dihydroartemisinin, diminish mitogen-induced lymphocyte proliferation and activation.

1 reference

12 December 2020

Apoptosis. Molecules and mechanisms.

1 reference

12 December 2020

Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.

1 reference

12 December 2020

Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer

1 reference

12 December 2020

Oral administration of dihydroartemisinin and ferrous sulfate retarded implanted fibrosarcoma growth in the rat.

1 reference

12 December 2020

Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases

1 reference

12 December 2020

10.1007/S11010-011-0716-6

Identifiers

DOI

1 reference

13 September 2017

1 reference